Evidence map›Paper›PMID 32814819›Full record

ArticleActa pharmacologica Sinica2021

A novel Diels-Alder adduct of mulberry leaves exerts anticancer effect through autophagy-mediated cell death.

Yu-Han Shu, Hua-Hua Yuan, Meng-Ting Xu, Ye-Ting Hong, Cheng-Cheng Gao, Zhi-Pan Wu, Hao-Te Han, Xin Sun, Rui-Lan Gao, Si-Fu Yang and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals.Bioengineering (Basel, Switzerland) · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Roles of Phytochemicals in Cancer Prevention and Therapeutics.International journal of molecular sciences · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Yu-Han Shu *College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310058, China.
Hua-Hua Yuan *College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310058, China.
Meng-Ting Xu *College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310058, China.
Ye-Ting Hong *Hangzhou Medical College, Hangzhou, 310053, China.
Cheng-Cheng GaoCollege of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310058, China.
Zhi-Pan WuCollege of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310058, China.
Hao-Te HanCollege of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310058, China.
Xin SunDepartment of Oncology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
Rui-Lan GaoDepartment of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China.
Si-Fu YangDepartment of Oncology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
Shou-Xin LiCollege of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310058, China.
Jing-Kui TianCollege of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310058, China. tjk@zju.edu.cn.
Jian-Bin ZhangClinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China. zhangjianbin@hmc.edu.cn.
Zhejiang University · CNZhejiang Provincial People's Hospital · CNHangzhou Medical College · CNMinistry of Education · MYZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guangsangon E (GSE) is a novel Diels-Alder adduct isolated from leaves of Morus alba L, a traditional Chinese medicine widely applied in respiratory diseases. It is reported that GSE has cytotoxic effect on cancer cells. In our research, we investigated its anticancer effect on respiratory cancer and revealed that GSE induces autophagy and apoptosis in lung and nasopharyngeal cancer cells. We first observed that GSE inhibits cell proliferation and induces apoptosis in A549 and CNE1 cells. Meanwhile, the upregulation of autophagosome marker LC3 and increased formation of GFP-LC3 puncta demonstrates the induction of autophagy in GSE-treated cells. Moreover, GSE increases the autophagy flux by enhancing lysosomal activity and the fusion of autophagosomes and lysosomes. Next, we investigated that endoplasmic reticulum (ER) stress is involved in autophagy induction by GSE. GSE activates the ER stress through reactive oxygen species (ROS) accumulation, which can be blocked by ROS scavenger NAC. Finally, inhibition of autophagy attenuates GSE-caused cell death, termed as "autophagy-mediated cell death." Taken together, we revealed the molecular mechanism of GSE against respiratory cancer, which demonstrates great potential of GSE in the treatment of representative cancer.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisAutophagyBenzofuransCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorEndoplasmic Reticulum StressFemaleHumansMiceMice, Inbred BALB CMice, NudeMorusNeoplasmsAntineoplastic Agents, PhytogenicBenzofuransguangsangon EReactive Oxygen SpeciesResorcinolsautophagyER stressGuangsangon Erespiratory cancer

Identifiers

PMID32814819
PMCPMC8115316
OpenAlexW3069176424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.